<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Although the precise nature of <z:hpo ids='HP_0003613'>Antiphospholipid antibodies</z:hpo> is still not clearly defined, they are known to have association with <z:hpo ids='HP_0001907'>thromboembolic events</z:hpo> and have been found in <z:hpo ids='HP_0012115'>hepatitis</z:hpo> C virus (HCV) <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Moreover, high prevalence of HCV <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> and thrombotic risk is described in <z:e sem="disease" ids="C0039730" disease_type="Disease or Syndrome" abbrv="">thalassemia</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>We aimed at investigating the prevalence of anticardiolipin antibodies (aCLAbs), <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> (LA), and their relation with HCV <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> in Iranian thalassemic patients </plain></SENT>
<SENT sid="3" pm="."><plain>Presence of anti-HCV antibody, serum HCV-<z:chebi fb="40" ids="33697">RNA</z:chebi>, aCLAbs, and LA activity was determined in 131 patients with <z:e sem="disease" ids="C0002875" disease_type="Disease or Syndrome" abbrv="">thalassemia major</z:e> (male/female: 63/68 aged 3-29 years) registered at <z:e sem="disease" ids="C0039730" disease_type="Disease or Syndrome" abbrv="">thalassemia</z:e> unit, Dastgheib Hospital, Shiraz, Iran </plain></SENT>
<SENT sid="4" pm="."><plain>Sixty-one healthy controls were also included </plain></SENT>
<SENT sid="5" pm="."><plain>Anti-HCV antibody was positive in 24 (18.3%), IgG aCLAbs in 56 (42.7%), and LA activity in 9 (6.9%) patients </plain></SENT>
<SENT sid="6" pm="."><plain>87.5% of patients positive for aCLAbs had a low titer of aCLAbs </plain></SENT>
<SENT sid="7" pm="."><plain>Although none of the participants had a previous history of <z:mp ids='MP_0005048'>thrombosis</z:mp>, higher prevalence of aCLAbs was detected in thalassemic patients compared with controls </plain></SENT>
<SENT sid="8" pm="."><plain>No significant difference in the prevalence of aCLAbs was found between HCV-infected and noninfected patients </plain></SENT>
<SENT sid="9" pm="."><plain>A high prevalence of aCLAbs, the majority in low titers, was detected in Iranian thalassemic patients irrespective of previous history of <z:mp ids='MP_0005048'>thrombosis</z:mp> and presence of HCV <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> </plain></SENT>
</text></document>